Suppr超能文献

[1200毫克利福平(力复平)用于女性单纯性淋病的口服单剂量治疗]

[1,200 mg rifampicin(Rimactan) as an oral one-dose treatment of uncomplicated gonorrhea in women].

作者信息

Schwarzenbach H R, Rufli T, Glaus L, Bergamini N

出版信息

Dermatologica. 1983;167(5):262-6.

PMID:6653852
Abstract

40 women were treated for uncomplicated genital gonorrhoea, verified by culture, with a single oral dose of 1,200 mg rifampicin (Rimactan). The ages ranged between 15 and 51 years. In 33 patients that could be evaluated, the gonorrhoea was cured. In 8 of 18 patients the preexistent vaginal discharge improved. 4 women experienced six different side effects which were probably related to rifampicin. The 1,200-mg rifampicin oral one-dose treatment is a reliable, efficient, and well-tolerated therapy of uncomplicated gonorrhoea in women.

摘要

40名经培养确诊为单纯性生殖器淋病的女性接受了单剂量口服1200毫克利福平(利福平胶囊)的治疗。年龄范围在15至51岁之间。在33名可评估的患者中,淋病得到治愈。18名患者中有8名先前存在的阴道分泌物有所改善。4名女性出现了六种可能与利福平有关的不同副作用。1200毫克利福平单剂量口服治疗是一种可靠、有效且耐受性良好的女性单纯性淋病治疗方法。

相似文献

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验